EP3448399A4 - Verfahren und system zur charakterisierung von hautbezogenen bedingungen - Google Patents

Verfahren und system zur charakterisierung von hautbezogenen bedingungen Download PDF

Info

Publication number
EP3448399A4
EP3448399A4 EP17790288.9A EP17790288A EP3448399A4 EP 3448399 A4 EP3448399 A4 EP 3448399A4 EP 17790288 A EP17790288 A EP 17790288A EP 3448399 A4 EP3448399 A4 EP 3448399A4
Authority
EP
European Patent Office
Prior art keywords
related conditions
characterizing skin
characterizing
skin
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17790288.9A
Other languages
English (en)
French (fr)
Other versions
EP3448399A1 (de
Inventor
Zachary APTE
Jessica RICHMAN
Catalina Valdivia
Daniel Almonacid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3448399A1 publication Critical patent/EP3448399A1/de
Publication of EP3448399A4 publication Critical patent/EP3448399A4/de
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Zoology (AREA)
  • Theoretical Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP17790288.9A 2016-04-25 2017-04-25 Verfahren und system zur charakterisierung von hautbezogenen bedingungen Pending EP3448399A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662327089P 2016-04-25 2016-04-25
US201662327048P 2016-04-25 2016-04-25
US201662327126P 2016-04-25 2016-04-25
PCT/US2017/029470 WO2017189614A1 (en) 2016-04-25 2017-04-25 Method and system for characterizing skin related conditions

Publications (2)

Publication Number Publication Date
EP3448399A1 EP3448399A1 (de) 2019-03-06
EP3448399A4 true EP3448399A4 (de) 2020-05-13

Family

ID=60160002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17790288.9A Pending EP3448399A4 (de) 2016-04-25 2017-04-25 Verfahren und system zur charakterisierung von hautbezogenen bedingungen

Country Status (5)

Country Link
EP (1) EP3448399A4 (de)
CN (1) CN109152803B (de)
AU (1) AU2017257785A1 (de)
CA (1) CA3022294A1 (de)
WO (1) WO2017189614A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973890B2 (en) 2016-09-13 2021-04-13 Allergan, Inc. Non-protein clostridial toxin compositions

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105593372A (zh) 2013-06-18 2016-05-18 普罗皮肤检测股份有限公司 基于皮肤菌群的分析的定制皮肤护理品和个人护理品
CA3055930A1 (en) 2017-03-10 2018-09-13 Prodermiq, Inc. Customized skin care products and personal care products based on the analysis of skin flora
WO2019191141A1 (en) * 2018-03-26 2019-10-03 Prodermiq, Inc. Compositions and methods for the treatment of acne
AU2019242894B2 (en) * 2018-03-29 2024-12-05 Kimberly-Clark Worldwide, Inc. Sensor for indicating a potential forthcoming skin or gastrointestinal issue and methods of using the same
US20250288700A1 (en) * 2021-07-05 2025-09-18 Conopco, Inc., D/B/A Unilever Method for evaluating a cosmetic composition or component thereof
BR112023025646A2 (pt) * 2021-07-05 2024-02-27 Unilever Ip Holdings B V Método de avaliação de pele
CN117337901B (zh) * 2023-09-28 2026-04-24 广西农垦西江乳业有限公司 一种低致敏乳源蛋白基料的制备方法
CN118272552B (zh) * 2024-03-29 2025-02-14 美益添生物医药(武汉)有限公司 源于肠道菌群的白癜风检测标志物及其应用
CN118230890A (zh) * 2024-05-24 2024-06-21 西安润玉医疗科技有限公司 一种基于术后皮肤检测数据的产品匹配方法及系统

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142378A1 (en) * 2012-03-17 2013-09-26 The Regents Of The University Of California Fast diagnosis and personalized treatments for acne
WO2014205088A2 (en) * 2013-06-18 2014-12-24 Prodermiq Customized skin care products and personal care products based on the analysis of skin flora
WO2015070086A1 (en) * 2013-11-07 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Cell-free nucleic acids for the analysis of the human microbiome and components thereof
WO2015112352A2 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
WO2016065075A1 (en) * 2014-10-21 2016-04-28 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
WO2016168350A1 (en) * 2015-04-13 2016-10-20 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
WO2017156031A1 (en) * 2016-03-07 2017-09-14 uBiome, Inc. Method and system for characterizing mouth-associated conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012098238A1 (en) * 2011-01-21 2012-07-26 Novimmune S.A. Combination therapies and methods using anti-cd3 modulating agents and anti-il-6 antagonists
WO2012158818A2 (en) * 2011-05-16 2012-11-22 Fabion Pharmaceuticals, Inc. Multi-specific fab fusion proteins and methods of use
US10131710B2 (en) * 2013-01-14 2018-11-20 Xencor, Inc. Optimized antibody variable regions
WO2014131711A1 (en) * 2013-02-26 2014-09-04 Roche Glycart Ag Bispecific t cell activating antigen binding molecules
JP6501270B2 (ja) * 2013-03-14 2019-04-17 ザ カリフォルニア インスティテュート フォー バイオメディカル リサーチ 標的化剤抗体抱合体およびその使用

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013142378A1 (en) * 2012-03-17 2013-09-26 The Regents Of The University Of California Fast diagnosis and personalized treatments for acne
WO2014205088A2 (en) * 2013-06-18 2014-12-24 Prodermiq Customized skin care products and personal care products based on the analysis of skin flora
WO2015070086A1 (en) * 2013-11-07 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Cell-free nucleic acids for the analysis of the human microbiome and components thereof
WO2015112352A2 (en) * 2014-01-25 2015-07-30 uBiome, Inc. Method and system for microbiome analysis
WO2016065075A1 (en) * 2014-10-21 2016-04-28 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics
WO2016168350A1 (en) * 2015-04-13 2016-10-20 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
WO2017156031A1 (en) * 2016-03-07 2017-09-14 uBiome, Inc. Method and system for characterizing mouth-associated conditions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973890B2 (en) 2016-09-13 2021-04-13 Allergan, Inc. Non-protein clostridial toxin compositions
US12144847B2 (en) 2016-09-13 2024-11-19 Allergan, Inc. Non-protein clostridial toxin compositions
US12171816B2 (en) 2016-09-13 2024-12-24 Allergan, Inc. Non-protein Clostridial toxin compositions

Also Published As

Publication number Publication date
CN109152803B (zh) 2022-09-23
EP3448399A1 (de) 2019-03-06
WO2017189614A1 (en) 2017-11-02
CA3022294A1 (en) 2017-11-02
AU2017257785A1 (en) 2018-11-08
CN109152803A (zh) 2019-01-04

Similar Documents

Publication Publication Date Title
EP3507742A4 (de) System und verfahren zur charakterisierung von cannabaceae-pflanzen
EP3635621A4 (de) System und verfahren zur bildanonymisierung
EP3811316C0 (de) Blockchain system und verfahren
EP3552137A4 (de) System und verfahren zur erkennung von cryptoware
EP3485435A4 (de) System und verfahren zur automatischen lernen von funktionen
EP3673345A4 (de) System und verfahren zur verfolgung verteilter vorrichtungen
EP3443685C0 (de) System und verfahren zur strahlverwaltung
EP3576707C0 (de) System und verfahren zur benutzerabsichtserkennung
EP3596960A4 (de) Präzises positionierungssystem und verfahren zur verwendung desselben
EP3697736C0 (de) System zur bereitstellung von markierten behältern und verfahren dafür
EP3844553C0 (de) Verfahren und system zur blickkalkulation
EP3349040C0 (de) Verfahren zur positionierung von unterwasserobjekten und system zur durchführung davon
EP3548440A4 (de) Flüssigkeitsbehandlungssysteme und verfahren zur verwendung davon
EP3503033C0 (de) System zur optischen verfolgung und verfahren zur optischen verfolgung
EP3308608C0 (de) System und verfahren zur visuellen verfolgung
EP3640333A4 (de) System und verfahren zur geneditierung
EP3422939A4 (de) Verfahren und system zur bildgebung
EP3600549A4 (de) System und verfahren zur bereitstellung von strahlentherapie
DE112018000901A5 (de) Verfahren und Vorrichtung zur Beatmung
EP3544648A4 (de) Chirurgisches system und verfahren zur verwendung
EP3079098C0 (de) Verfahren und system zur geodemografischen klassifizierung einer geografischen region
EP3512423A4 (de) System und verfahren zur charakterisierung von atemstress
EP3416536C0 (de) Winguide und verfahren zur verwendung davon
EP3584731A4 (de) Verfahren und system zur authentifizierungsverwaltung
EP3828338C0 (de) System und verfahren zur überwachung eines applikationsstabs

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181024

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0035740000

Ipc: C12Q0001689000

A4 Supplementary search report drawn up and despatched

Effective date: 20200417

RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 17/00 20190101ALI20200408BHEP

Ipc: C12Q 1/689 20180101AFI20200408BHEP

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230905